眼神经:临床特征,诊断和结果
Tia B Bodi1, Lindsay D Klaehn1, Andrea M Kramer1
1From the Department of Ophthalmology, Mayo Clinic College of Medicine (T.B.B., L.D.K., A.M.K., J.A.L., J.A.G., S.A.M.), Rochester, Minnesota.
American journal of ophthalmology
|February 18, 2024
概括
眼神经,通常是由头骨辐射引起的,经常影响第六个头骨神经. 尽管常见的错误诊断,医疗治疗导致大多数患者的症状显著改善.
科学领域:
- 眼科医生 眼科 眼科
- 神经学 神经学
- 神经眼科 神经眼科
背景情况:
- 眼神经 (OMN) 是一种罕见的疾病,其特点是间歇性,自发性,经常痛苦的眼肌功能障碍.
- 它经常与先前的头骨辐射疗法有关,导致神经损伤延迟.
研究的目的:
- 描述一大群OMN患者的临床特征,管理策略,患者结果和诊断挑战.
- 确定与OMN相关的常见原因和诊断陷.
主要方法:
- 2004年1月1日至2023年1月1日期间被诊断患有OMN的患者的回顾性队列研究.
- 从梅奥诊所三个地点的医疗记录中收集数据,重点关注临床表现,治疗和结果.
主要成果:
- 该研究包括42名患者,平均年龄为58岁. 93%的人有脑辐射病史.
- 第六个神经最常受到影响 (74%). 诊断的中位时间为8个月,其中52%的患者经历了最初的误诊.
- 48%的患者接受了口服药物治疗,在95%的病例中实现了显著的症状改善或消失.
结论:
- 脑前辐射是OMN的主要病因,经常涉及第六个脑神经.
- 延迟诊断和初始错误诊断很普遍,但医疗管理提供了相当大的治疗效益.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Myasthenia Gravis: Diagnostic Tests
840
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
840
Disorders of the Skeletal Muscle
948
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
948
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Chemical Synapses
8.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K


